Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00316407 · ClinicalTrials.gov registry record · Phase 1
Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients
A Phase 1 study, sponsored by Swedish Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00316407 is a Phase 1 study that has completed, run by Swedish Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT00316407, a Phase 1 study, has completed, sponsored by Swedish Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness, safety, tolerability and best dose of Lapatinib (GW572016) in combination with carboplatin and paclitaxel.
Interventions
- DRUG Carboplatin
- DRUG Paclitaxel
- DRUG lapatinib (GW572016)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00316407
The ClinicalTrials.gov registry entry for NCT00316407 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swedish Medical Center, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Carboplatin is the first listed.
NCT00316407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00316407 about?
NCT00316407 is a clinical study titled "Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients". The purpose of this study is to determine the effectiveness, safety, tolerability and best dose of Lapatinib (GW572016) in combination with carboplatin and paclitaxel.
What is the current status of trial NCT00316407?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2005-08. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00316407?
The interventions under investigation include: Carboplatin (DRUG), Paclitaxel (DRUG), lapatinib (GW572016) (DRUG).
Who is sponsoring clinical trial NCT00316407?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.